Answers are grounded in this paper and cite their sources.
Lithium carbonate has multifaceted immunomodulatory effects. This report describes a case of joint symptom exacerbation in rheumatoid arthritis (RA) following oral lithium carbonate administration, in which an elevation in C-reactive protein (CRP) levels and an increase in neutrophil count preceded the onset of polyarthralgia. The patient was a 49-year-old woman in remission with normal CRP levels. After starting oral lithium carbonate for manic symptoms, an increase in neutrophil count and elevated CRP levels were observed within 7days. Only after the dose escalation, the patient complained of polyarthralgia with moderate disease activity. As lithium carbonate was gradually tapered, her joint symptoms improved progressively. Lithium carbonate therapy may exacerbate joint symptoms of RA. Elevated CRP levels were observed prior to lithium-associated polyarthralgia. CRP might serve as an early indicator of lithium-associated systemic inflammation and subsequent joint symptom exacerbation.
No takes yet. Share an insight, caveat, or question.
Kozuki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: